MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Edwards Lifesciences Corp

Fermé

SecteurSoins de santé

72.08 0.45

Résumé

Variation du prix de l'action

24h

Actuel

Min

70.64

Max

72.34

Chiffres clés

By Trading Economics

Revenu

-2.7B

346M

Ventes

31M

1.4B

P/E

Moyenne du Secteur

30.714

63.778

BPA

0.59

Marge bénéficiaire

24.989

Employés

15,800

EBITDA

55M

484M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+7.89% upside

Dividendes

By Dow Jones

Prochains Résultats

23 avr. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.1B

42B

Ouverture précédente

71.63

Clôture précédente

72.08

Sentiment de l'Actualité

By Acuity

22%

78%

55 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Edwards Lifesciences Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 juil. 2024, 13:57 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Buy Innovalve for $300 Million

25 oct. 2024, 09:10 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25 oct. 2024, 08:35 UTC

Résultats

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3 sept. 2024, 20:38 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 sept. 2024, 20:37 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 sept. 2024, 20:36 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25 juil. 2024, 09:02 UTC

Résultats
Actions en Tendance

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25 juil. 2024, 08:40 UTC

Actualités

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24 juil. 2024, 20:17 UTC

Résultats

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24 juil. 2024, 20:15 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Sales $1.39B >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Net $366.3M >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q Adj EPS 70c >EW

24 juil. 2024, 20:15 UTC

Résultats

Edwards Lifesciences 2Q EPS 61c >EW

15 juil. 2024, 13:42 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Buy Innovalve for $300M

15 juil. 2024, 13:01 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15 juil. 2024, 13:01 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15 juil. 2024, 13:00 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15 juil. 2024, 13:00 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences To Acquire Innovalve >EW

4 juin 2024, 17:26 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 juin 2024, 13:26 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 juin 2024, 12:25 UTC

Actualités
Acquisitions, Fusions, Rachats

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 juin 2024, 11:03 UTC

Actualités
Acquisitions, Fusions, Rachats

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 juin 2024, 10:40 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 juin 2024, 10:32 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 juin 2024, 10:31 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 juin 2024, 10:31 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 juin 2024, 10:30 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 juin 2024, 10:30 UTC

Acquisitions, Fusions, Rachats

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

26 avr. 2024, 20:10 UTC

Résultats

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

Comparaison

Variation de prix

Edwards Lifesciences Corp prévision

Objectif de Prix

By TipRanks

7.89% hausse

Prévisions sur 12 Mois

Moyen 77.54 USD  7.89%

Haut 90 USD

Bas 60 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

19 ratings

7

Achat

11

Maintien

1

Vente

Score Technique

By Trading Central

71.2 / 72.48Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

55 / 386Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.